home.social

#biotech — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #biotech, aggregated by home.social.

  1. #Formaldehyd ist seit 2015 als wahrscheinlich #karzinogen eingestuft. LICIT Solutions aus Tübingen hat mit Aminolipin eine mögliche Alternative für die Konservierung toter Körper wie auch biologischer Proben für die #Histologie gefunden: laborjournal.de/editorials/349 #StartUp #Biotech

  2. #Formaldehyd ist seit 2015 als wahrscheinlich #karzinogen eingestuft. LICIT Solutions aus Tübingen hat mit Aminolipin eine mögliche Alternative für die Konservierung toter Körper wie auch biologischer Proben für die #Histologie gefunden: laborjournal.de/editorials/349 #StartUp #Biotech

  3. #Formaldehyd ist seit 2015 als wahrscheinlich #karzinogen eingestuft. LICIT Solutions aus Tübingen hat mit Aminolipin eine mögliche Alternative für die Konservierung toter Körper wie auch biologischer Proben für die #Histologie gefunden: laborjournal.de/editorials/349 #StartUp #Biotech

  4. #Formaldehyd ist seit 2015 als wahrscheinlich #karzinogen eingestuft. LICIT Solutions aus Tübingen hat mit Aminolipin eine mögliche Alternative für die Konservierung toter Körper wie auch biologischer Proben für die #Histologie gefunden: laborjournal.de/editorials/349 #StartUp #Biotech

  5. #Formaldehyd ist seit 2015 als wahrscheinlich #karzinogen eingestuft. LICIT Solutions aus Tübingen hat mit Aminolipin eine mögliche Alternative für die Konservierung toter Körper wie auch biologischer Proben für die #Histologie gefunden: laborjournal.de/editorials/349 #StartUp #Biotech

  6. #Newswire: StrainX Bioworks has raised $13 million in a round led by Prime Venture Partners and Leo Capital as it emerges from two years of stealth-mode development. The India-based synthetic biology and microbial fermentation company has built an integrated platform spanning strain engineering, fermentation, and product development, and has demonstrated operations at 10,000-liter scale.

    #SyntheticBiology #Fermentation #Biotech #FoodIngredients #India

    proteinreport.org/newswire/str

  7. #Newswire: StrainX Bioworks has raised $13 million in a round led by Prime Venture Partners and Leo Capital as it emerges from two years of stealth-mode development. The India-based synthetic biology and microbial fermentation company has built an integrated platform spanning strain engineering, fermentation, and product development, and has demonstrated operations at 10,000-liter scale.

    #SyntheticBiology #Fermentation #Biotech #FoodIngredients #India

    proteinreport.org/newswire/str

  8. #Newswire: StrainX Bioworks has raised $13 million in a round led by Prime Venture Partners and Leo Capital as it emerges from two years of stealth-mode development. The India-based synthetic biology and microbial fermentation company has built an integrated platform spanning strain engineering, fermentation, and product development, and has demonstrated operations at 10,000-liter scale.

    #SyntheticBiology #Fermentation #Biotech #FoodIngredients #India

    proteinreport.org/newswire/str

  9. #Newswire: StrainX Bioworks has raised $13 million in a round led by Prime Venture Partners and Leo Capital as it emerges from two years of stealth-mode development. The India-based synthetic biology and microbial fermentation company has built an integrated platform spanning strain engineering, fermentation, and product development, and has demonstrated operations at 10,000-liter scale.

    #SyntheticBiology #Fermentation #Biotech #FoodIngredients #India

    proteinreport.org/newswire/str

  10. #Newswire: StrainX Bioworks has raised $13 million in a round led by Prime Venture Partners and Leo Capital as it emerges from two years of stealth-mode development. The India-based synthetic biology and microbial fermentation company has built an integrated platform spanning strain engineering, fermentation, and product development, and has demonstrated operations at 10,000-liter scale.

    #SyntheticBiology #Fermentation #Biotech #FoodIngredients #India

    proteinreport.org/newswire/str

  11. U.S. lawmakers push a Biotech Workforce Bill to beat China in biotech.
    🚀 Key insight: Funding will focus on training, research & STEM education, expanding the domestic talent pool.
    - Boosts R&D capacity
    - Diversifies expertise in biotech hubs
    - Aims to keep the U.S. ahead in global biotech leadership

    #Biotech #WorkforceDevelopment #Innovation #Privacy #Decentralization

    🔗 news.google.com/rss/articles/C

  12. 🔥 TRENDING

    📢 نماذج القيمة العادلة من InvestingPro ترصد تقييماً مبالغاً فيه لسهم Sana Biotech بواسطة Investing.com - Investing.com

    🔗 news.google.com/rss/articles/C

    #Investingpro #Sana #Biotech #Investing.com #GlobalFeed #News #ARABIC

    *Automatically posted by Global Feed Bot*

  13. 📰 BIOTECH CATALYST

    Merck partner Kelun outlines Phase 3 lung cancer success in China study

    The study's success could bolster Merck's (NYSE…

    In today's briefing →
    burns-media.com/biotech/archiv

    #Biotech #FDA

  14. 📰 BIOTECH CATALYST

    Merck partner Kelun outlines Phase 3 lung cancer success in China study

    The study's success could bolster Merck's (NYSE…

    In today's briefing →
    burns-media.com/biotech/archiv

    #Biotech #FDA

  15. 📰 BIOTECH CATALYST

    Merck partner Kelun outlines Phase 3 lung cancer success in China study

    The study's success could bolster Merck's (NYSE…

    In today's briefing →
    burns-media.com/biotech/archiv

    #Biotech #FDA

  16. 📰 BIOTECH CATALYST

    Merck partner Kelun outlines Phase 3 lung cancer success in China study

    The study's success could bolster Merck's (NYSE…

    In today's briefing →
    burns-media.com/biotech/archiv

    #Biotech #FDA

  17. 📰 BIOTECH CATALYST

    Merck partner Kelun outlines Phase 3 lung cancer success in China study

    The study's success could bolster Merck's (NYSE…

    In today's briefing →
    burns-media.com/biotech/archiv

    #Biotech #FDA

  18. #Endometriose trifft jede zehnte Frau – aber die #Diagnose dauert oft Jahre. Marlene Rezk-Füreder und ihr Team vom #Startup Diamens in Linz nutzen Menstruationsblut als #Biomarker -Quelle. Bettina Dupont hat mit ihr gesprochen:
    laborjournal.de/editorials/3492.php #biotech #lifescience

  19. #Endometriose trifft jede zehnte Frau – aber die #Diagnose dauert oft Jahre. Marlene Rezk-Füreder und ihr Team vom #Startup Diamens in Linz nutzen Menstruationsblut als #Biomarker -Quelle. Bettina Dupont hat mit ihr gesprochen:
    laborjournal.de/editorials/3492.php #biotech #lifescience

  20. Muck Rack Secures STAT Content Deal, Bolstering Health Sector Monitoring

    Muck Rack now includes STAT's health and medicine news. This helps health companies track industry news more easily.

    #MuckRack, #STATNews, #HealthTech, #Biotech, #PharmaNews

    newsletter.tf/muck-rack-adds-s

  21. Muck Rack, which tracks news from over 600,000 sources, has added STAT's health reporting. This gives users more access to important health industry news.

    #MuckRack, #STATNews, #HealthTech, #Biotech, #PharmaNews
    newsletter.tf/muck-rack-adds-s

  22. 📰 BIOTECH CATALYST

    Bayer granted priority review for Kerendia label expansion in U.S.

    A successful label expansion could significantly boost…

    In today's briefing →
    burns-media.com/biotech/archiv

    #Biotech #FDA

  23. 📰 BIOTECH CATALYST

    Bayer granted priority review for Kerendia label expansion in U.S.

    A successful label expansion could significantly boost…

    In today's briefing →
    burns-media.com/biotech/archiv

    #Biotech #FDA

  24. 📰 BIOTECH CATALYST

    Bayer granted priority review for Kerendia label expansion in U.S.

    A successful label expansion could significantly boost…

    In today's briefing →
    burns-media.com/biotech/archiv

    #Biotech #FDA

  25. 📰 BIOTECH CATALYST

    Bayer granted priority review for Kerendia label expansion in U.S.

    A successful label expansion could significantly boost…

    In today's briefing →
    burns-media.com/biotech/archiv

    #Biotech #FDA

  26. 📰 BIOTECH CATALYST

    Bayer granted priority review for Kerendia label expansion in U.S.

    A successful label expansion could significantly boost…

    In today's briefing →
    burns-media.com/biotech/archiv

    #Biotech #FDA

  27. #US taps small #SanDiego #biotech for experimental #Ebola treatment as epidemic worsens
    Biotech, #MappBiopharmaceutical, “has shipped doses for potential use in high-risk individuals,” a spokesperson for HHS said, “as part of coordinated preparedness efforts.”
    The antibody was originally developed in collaboration with the B-ARPA for Sudan virus, a species of #ebolavirus separate from the #Bundibugyo species that is causing the current epidemic.
    fiercebiotech.com/biotech/us-t
    archive.ph/JXeDb

  28. #US taps small #SanDiego #biotech for experimental #Ebola treatment as epidemic worsens
    Biotech, #MappBiopharmaceutical, “has shipped doses for potential use in high-risk individuals,” a spokesperson for HHS said, “as part of coordinated preparedness efforts.”
    The antibody was originally developed in collaboration with the B-ARPA for Sudan virus, a species of #ebolavirus separate from the #Bundibugyo species that is causing the current epidemic.
    fiercebiotech.com/biotech/us-t
    archive.ph/JXeDb

  29. taps small for experimental treatment as epidemic worsens
    Biotech, , “has shipped doses for potential use in high-risk individuals,” a spokesperson for HHS said, “as part of coordinated preparedness efforts.”
    The antibody was originally developed in collaboration with the B-ARPA for Sudan virus, a species of separate from the species that is causing the current epidemic.
    fiercebiotech.com/biotech/us-t
    archive.ph/JXeDb

  30. #US taps small #SanDiego #biotech for experimental #Ebola treatment as epidemic worsens
    Biotech, #MappBiopharmaceutical, “has shipped doses for potential use in high-risk individuals,” a spokesperson for HHS said, “as part of coordinated preparedness efforts.”
    The antibody was originally developed in collaboration with the B-ARPA for Sudan virus, a species of #ebolavirus separate from the #Bundibugyo species that is causing the current epidemic.
    fiercebiotech.com/biotech/us-t
    archive.ph/JXeDb

  31. #US taps small #SanDiego #biotech for experimental #Ebola treatment as epidemic worsens
    Biotech, #MappBiopharmaceutical, “has shipped doses for potential use in high-risk individuals,” a spokesperson for HHS said, “as part of coordinated preparedness efforts.”
    The antibody was originally developed in collaboration with the B-ARPA for Sudan virus, a species of #ebolavirus separate from the #Bundibugyo species that is causing the current epidemic.
    fiercebiotech.com/biotech/us-t
    archive.ph/JXeDb

  32. 🐍💉 Tim Friede spent nearly 20 years gradually immunizing himself against #venom from over a dozen deadly #snakes, including #cobras and black #mambas.

    Scientists used #antibodies from his blood to create an experimental #antivenom that protected #mice from 13 types of snake venom. The work could lead to a single broad-spectrum antivenom.

    👉 sciencenews.org/article/antive

    #science #immunology #biology #wildlife #medicine #research #nature #wisconsin #newyork #biotech

  33. 🐍💉 Tim Friede spent nearly 20 years gradually immunizing himself against #venom from over a dozen deadly #snakes, including #cobras and black #mambas.

    Scientists used #antibodies from his blood to create an experimental #antivenom that protected #mice from 13 types of snake venom. The work could lead to a single broad-spectrum antivenom.

    👉 sciencenews.org/article/antive

    #science #immunology #biology #wildlife #medicine #research #nature #wisconsin #newyork #biotech

  34. 🐍💉 Tim Friede spent nearly 20 years gradually immunizing himself against #venom from over a dozen deadly #snakes, including #cobras and black #mambas.

    Scientists used #antibodies from his blood to create an experimental #antivenom that protected #mice from 13 types of snake venom. The work could lead to a single broad-spectrum antivenom.

    👉 sciencenews.org/article/antive

    #science #immunology #biology #wildlife #medicine #research #nature #wisconsin #newyork #biotech

  35. 🐍💉 Tim Friede spent nearly 20 years gradually immunizing himself against #venom from over a dozen deadly #snakes, including #cobras and black #mambas.

    Scientists used #antibodies from his blood to create an experimental #antivenom that protected #mice from 13 types of snake venom. The work could lead to a single broad-spectrum antivenom.

    👉 sciencenews.org/article/antive

    #science #immunology #biology #wildlife #medicine #research #nature #wisconsin #newyork #biotech

  36. 🐍💉 Tim Friede spent nearly 20 years gradually immunizing himself against #venom from over a dozen deadly #snakes, including #cobras and black #mambas.

    Scientists used #antibodies from his blood to create an experimental #antivenom that protected #mice from 13 types of snake venom. The work could lead to a single broad-spectrum antivenom.

    👉 sciencenews.org/article/antive

    #science #immunology #biology #wildlife #medicine #research #nature #wisconsin #newyork #biotech

  37. Colossal ha fatto schiudere 26 pulcini da un uovo artificiale: un reticolo stampato in 3D e una membrana trasparente che ti fa vedere l'embrione crescere giorno per giorno. Un sogno per chi studia lo sviluppo in laboratorio. C'è però un dettaglio che ai ricercatori non va giù: l'azienda non ha pubblicato nessun dato, e non intende farlo. Ventisei nati su quante uova di partenza? Mistero. Lo strumento è notevole. La fiducia, tutta da guadagnare.

    futuroprossimo.it/2026/05/colo

    #biotech

  38. Das war die BOKU Future Conference 2026 zum Thema NO WASTE! 🌱

    Gestern (20. Mai 2026) drehte sich an der BOKU alles um die circular economy: Von Mikroorganismen als Zellfabriken über klimafreundliche Chemie bis zu innovativen Materialien aus erneuerbaren Rohstoffen.

    Forschende, Start-ups und Kunstprojekte haben gezeigt, wie interdisziplinäre Kooperation die nachhaltige Transformation beschleunigt. 🚀

    Mehr Infos & Nachlese:
    🔗 boku.ac.at/oeffentlichkeitsarb

    #BOKU #NoWaste #Sustainability #Biotech